当前位置:首页 - 行情中心 - 港通医疗(301515) - 财务分析 - 现金流量表

港通医疗

(301515)

  

流通市值:15.51亿  总市值:23.66亿
流通股本:6557.06万   总股本:1.00亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金193,304,290.31702,672,669.89437,452,721.74284,306,850.46
  收到的税费返还--0-
  收到其他与经营活动有关的现金1,870,268.5922,115,654.0517,540,909.2514,132,037.71
  经营活动现金流入小计195,174,558.9724,788,323.94454,993,630.99298,438,888.17
  购买商品、接受劳务支付的现金143,869,373.68453,909,326.82316,823,205.21199,917,795.26
  支付给职工以及为职工支付的现金33,915,897.59126,492,058.53101,273,513.2454,937,930.17
  支付的各项税费10,090,444.6447,641,890.3633,715,632.2523,688,507.98
  支付其他与经营活动有关的现金28,629,318.17107,840,647.9685,293,948.1359,043,674.44
  经营活动现金流出小计216,505,034.08735,883,923.67537,106,298.83337,587,907.85
  经营活动产生的现金流量净额-21,330,475.18-11,095,599.73-82,112,667.84-39,149,019.68
二、投资活动产生的现金流量:
  收回投资收到的现金460,000,000326,000,000326,000,000326,000,000
  取得投资收益收到的现金--0-
  处置固定资产、无形资产和其他长期资产收回的现金净额-47,0180-
  处置子公司及其他营业单位收到的现金净额--0-
  收到的其他与投资活动有关的现金3,502,140.513,628,254.764,359,032.534,359,032.53
  投资活动现金流入小计463,502,140.51329,675,272.76330,359,032.53330,359,032.53
  购建固定资产、无形资产和其他长期资产支付的现金8,769,782.1924,141,604.1315,375,867.548,456,996.52
  投资支付的现金-659,250,000653,250,000193,250,000
  取得子公司及其他营业单位支付的现金--0-
  支付其他与投资活动有关的现金--0-
  投资活动现金流出小计8,769,782.19683,391,604.13668,625,867.54201,706,996.52
  投资活动产生的现金流量净额454,732,358.32-353,716,331.37-338,266,835.01128,652,036.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金100,0001,000,0001,000,0001,000,000
  其中:子公司吸收少数股东投资收到的现金100,0001,000,0001,000,000-
  取得借款收到的现金69,000,000256,000,000221,000,000105,000,000
  收到其他与筹资活动有关的现金2,677,755.5640,069,228.537,271,502.676,977,971.42
  筹资活动现金流入小计71,777,755.56297,069,228.53229,271,502.67112,977,971.42
  偿还债务支付的现金40,000,000171,500,00094,800,00032,800,000
  分配股利、利润或偿付利息支付的现金1,413,041.1318,660,263.4214,475,266.62,728,837.44
  支付其他与筹资活动有关的现金5,370,274.78136,342,512.676,337,158.0567,972,560.83
  筹资活动现金流出小计46,783,315.91326,502,776.02185,612,424.65103,501,398.27
  筹资活动产生的现金流量净额24,994,439.65-29,433,547.4943,659,078.029,476,573.15
四、汇率变动对现金及现金等价物的影响-10,071.67-13,527.27-6,553.19-1,778.53
五、现金及现金等价物净增加额458,386,251.12-394,259,005.86-376,726,978.0298,977,810.95
  加:期初现金及现金等价物余额181,613,139.64575,872,145.5575,872,145.5575,872,145.5
  期末现金及现金等价物余额639,999,390.76181,613,139.64199,145,167.48674,849,956.45
补充资料:
  净利润--5,178,782.94--9,141,458.61
  资产减值准备-70,000,635.04-21,268,758.86
  固定资产和投资性房地产折旧-6,407,170.25-3,173,640.92
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-6,407,170.25-3,173,640.92
  无形资产摊销-1,088,679.58-495,016.71
  长期待摊费用摊销-1,355,762.27-356,897.36
  处置固定资产、无形资产和其他长期资产的损失--142,830.32--114,157.19
  固定资产报废损失-47,276.3-52,829.6
  公允价值变动损失----511,856.85
  财务费用-609,564.77-3,249,072.91
  投资损失--200,049.07--
  递延所得税--11,306,513.54--3,991,655
  其中:递延所得税资产减少--10,372,292.84--3,734,197.71
    递延所得税负债增加--934,220.7--257,457.29
  存货的减少--80,252,153.43--29,013,260.28
  经营性应收项目的减少--130,779,737.55--61,157,784.26
  经营性应付项目的增加-128,654,857.5-33,377,759.14
  其他-2,730,537.22--
  现金的期末余额-181,613,139.64-674,849,956.45
  减:现金的期初余额-575,872,145.5-575,872,145.5
  现金及现金等价物的净增加额--394,259,005.86-98,977,810.95
公告日期2026-04-242026-04-242025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑